Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial by Dimopoulos, Meletios A, Dr Prof, Trotman, Judith, Prof, Tedeschi, Alessandra, MD, Matous, Jeffrey V, Prof, Macdonald, David, MD, Tam, Constantine, MBBS, Tournilhac, Olivier, Prof, Ma, Shuo, MD, Oriol, Albert, MD, Heffner, Leonard T, MD, Shustik, Chaim, Prof, García-Sanz, Ramón, Prof, Cornell, Robert F, MD, de Larrea, Carlos Fernández, MD, Castillo, Jorge J, MD, Granell, Miquel, MD, Kyrtsonis, Marie-Christine, MD, Leblond, Veronique, Prof, Symeonidis, Argiris, MD, Kastritis, Efstathios, MD, Singh, Priyanka, MS, Li, Jianling, MS, Graef, Thorsten, MD, Bilotti, Elizabeth, MSN, Treon, Steven, MD, Buske, Christian, Prof

Get full text